FDA Clearance Tracker · K871246
IFA TEST FOR ANTIBODIES TO BORRELIA BURGDORFERI
Last checked: Nov 19, 2026Latest source record: Aug 25, 1987 (this decision)Source: openFDAMethods & limitations
Decided
Aug 25, 1987
Substantially Equivalent
Time to decision
151 days
Received Mar 27, 1987. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K871246
- Device name
- IFA TEST FOR ANTIBODIES TO BORRELIA BURGDORFERI
- Applicant
- Zeus Scientific, Inc.
- Applicant location
- Raritan, NJ
- Received
- Mar 27, 1987
- Decided
- Aug 25, 1987
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Reagent, Borrelia Serological Reagent (LSR)
- Device class
- Class II
- Regulation
- 21 CFR 866.3830
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code LSR (Reagent, Borrelia Serological Reagent).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Zeus Scientific, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K201956 · Decided Apr 29, 2022 · 654 days after receipt
Device type: Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control (DHN) · Laboratory Medicine & Pathology
K190907 · Decided Jul 29, 2019 · 112 days after receipt
Device type: Reagent, Borrelia Serological Reagent (LSR) · Laboratory Medicine & Pathology
K191240 · Decided Jul 29, 2019 · 82 days after receipt
Device type: Reagent, Borrelia Serological Reagent (LSR) · Laboratory Medicine & Pathology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.